A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
Liverpool Crown Court has heard that a young mother was attacked with a bottle after she tried to stop an argument
Firm is due to be sentenced after death of six year old girl in automatic gate
It may be the season of goodwill but for some Christmas is a lonely and distressing time. Here are some helpful tips on how to cope.